Literature DB >> 20457278

Pathogenesis of giant cell arteritis: More than just an inflammatory condition?

Kim-Heang Ly1, Alexis Régent, Mathieu C Tamby, Luc Mouthon.   

Abstract

Giant cell arteritis (GCA) is characterized by intimal hyperplasia and luminal obstruction leading to ischemic manifestations involving extra-cranial branches of carotid arteries and aorta. Histopathological lesions involve all layers of the arterial wall and are associated with multinucleated giant cells, fragmented internal elastic lamina and polymorphic cellular infiltrates, including T lymphocytes and macrophages. The pathophysiology of GCA is still poorly understood. After dendritic cell activation, CD4(+) T lymphocytes, T helper 1 (Th1) cells, produce interferon gamma and modulate macrophage activation and functions, and Th17 cells produce interleukin 17 (IL-17), which can induce cytokine production by macrophages and fibroblasts. Macrophages in the adventitia produce pro-inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor alpha. These cytokines promote arterial wall and systemic inflammation. Questions remain regarding the nature of the antigen(s) triggering dendritic cell activation and the mechanisms underlying vascular remodeling. Here we review recent advances in the pathogenesis of GCA, with emphasis on the interactions between cells of the immune system and components of the vessel wall, including vascular smooth muscle cells and endothelial cells, leading to vascular remodeling. Finally, we propose new areas of investigation that could help understand the triggering factors and key pathogenic events in GCA. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20457278     DOI: 10.1016/j.autrev.2010.05.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  23 in total

1.  Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Charat Thongprayoon; Kenneth J Warrington
Journal:  Ann Transl Med       Date:  2015-09

Review 2.  Recent Advances in Giant Cell Arteritis.

Authors:  M Guevara; C S Kollipara
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

Review 3.  Giant Cell Arteritis: 2018 Review.

Authors:  Anne Winkler; David True
Journal:  Mo Med       Date:  2018 Sep-Oct

Review 4.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

5.  A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Authors:  F David Carmona; Augusto Vaglio; Sarah L Mackie; José Hernández-Rodríguez; Paul A Monach; Santos Castañeda; Roser Solans; Inmaculada C Morado; Javier Narváez; Marc Ramentol-Sintas; Colin T Pease; Bhaskar Dasgupta; Richard Watts; Nader Khalidi; Carol A Langford; Steven Ytterberg; Luigi Boiardi; Lorenzo Beretta; Marcello Govoni; Giacomo Emmi; Francesco Bonatti; Marco A Cimmino; Torsten Witte; Thomas Neumann; Julia Holle; Verena Schönau; Laurent Sailler; Thomas Papo; Julien Haroche; Alfred Mahr; Luc Mouthon; Øyvind Molberg; Andreas P Diamantopoulos; Alexandre Voskuyl; Elisabeth Brouwer; Thomas Daikeler; Christoph T Berger; Eamonn S Molloy; Lorraine O'Neill; Daniel Blockmans; Benedicte A Lie; Paul Mclaren; Timothy J Vyse; Cisca Wijmenga; Yannick Allanore; Bobby P C Koeleman; Jennifer H Barrett; María C Cid; Carlo Salvarani; Peter A Merkel; Ann W Morgan; Miguel A González-Gay; Javier Martín
Journal:  Am J Hum Genet       Date:  2016-12-29       Impact factor: 11.025

6.  A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Authors:  F David Carmona; Sarah L Mackie; Jose-Ezequiel Martín; John C Taylor; Augusto Vaglio; Stephen Eyre; Lara Bossini-Castillo; Santos Castañeda; Maria C Cid; José Hernández-Rodríguez; Sergio Prieto-González; Roser Solans; Marc Ramentol-Sintas; M Francisca González-Escribano; Lourdes Ortiz-Fernández; Inmaculada C Morado; Javier Narváez; José A Miranda-Filloy; Lorenzo Beretta; Claudio Lunardi; Marco A Cimmino; Davide Gianfreda; Daniele Santilli; Giuseppe A Ramirez; Alessandra Soriano; Francesco Muratore; Giulia Pazzola; Olga Addimanda; Cisca Wijmenga; Torsten Witte; Jan H Schirmer; Frank Moosig; Verena Schönau; Andre Franke; Øyvind Palm; Øyvind Molberg; Andreas P Diamantopoulos; Simon Carette; David Cuthbertson; Lindsy J Forbess; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Paul A Monach; Christian Pagnoux; Philip Seo; Robert Spiera; Antoine G Sreih; Kenneth J Warrington; Steven R Ytterberg; Peter K Gregersen; Colin T Pease; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Richard Watts; Sarah Levy; Yusuf Patel; Sanjeet Kamath; Bhaskar Dasgupta; Jane Worthington; Bobby P C Koeleman; Paul I W de Bakker; Jennifer H Barrett; Carlo Salvarani; Peter A Merkel; Miguel A González-Gay; Ann W Morgan; Javier Martín
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

7.  Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

Authors:  Alexis Régent; Hanadi Dib; Kim H Ly; Christian Agard; Mathieu C Tamby; Nicolas Tamas; Babette Weksler; Christian Federici; Cédric Broussard; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-06-28       Impact factor: 5.156

Review 8.  The thromboembolic risk in giant cell arteritis: a critical review of the literature.

Authors:  A Guida; A Tufano; P Perna; P Moscato; M T De Donato; R Finelli; D Caputo; M N D Di Minno
Journal:  Int J Rheumatol       Date:  2014-05-20

9.  Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.

Authors:  Kim Heang Ly; Alexis Régent; Elsa Molina; Sofiane Saada; Philippe Sindou; Claire Le-Jeunne; Antoine Brézin; Véronique Witko-Sarsat; François Labrousse; Pierre-Yves Robert; Philippe Bertin; Jean-Louis Bourges; Anne-Laure Fauchais; Elisabeth Vidal; Luc Mouthon; Marie-Odile Jauberteau
Journal:  Arthritis Res Ther       Date:  2014-11-24       Impact factor: 5.156

10.  Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Authors:  A Serrano; A Márquez; S L Mackie; F D Carmona; R Solans; J A Miranda-Filloy; J Hernández-Rodríguez; M C Cid; S Castañeda; I C Morado; J Narváez; R Blanco; B Sopeña; M J García-Villanueva; J Monfort; N Ortego-Centeno; A Unzurrunzaga; B Marí-Alfonso; J Sánchez Martín; E de Miguel; C Magro; E Raya; N Braun; J Latus; O Molberg; B A Lie; F Moosig; T Witte; A W Morgan; M A González-Gay; J Martín
Journal:  Ann Rheum Dis       Date:  2013-08-14       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.